| scholarly article | Q13442814 |
| P50 | author | Michelle A Ozbun | Q59453176 |
| P2093 | author name string | Zurab Surviladze | |
| Agnieszka Dziduszko | |||
| P2860 | cites work | The nature of large noncovalent complexes containing glycosyl-phosphatidylinositol-anchored membrane glycoproteins and protein tyrosine kinases | Q41601365 |
| Signal transduction through MAP kinase cascades | Q41750250 | ||
| The epidermal growth factor receptor (EGFR) promotes uptake of influenza A viruses (IAV) into host cells | Q41867971 | ||
| Quantitative determination of EGF-R during epidermal wound healing | Q45013255 | ||
| Common and distinct elements in cellular signaling via EGF and FGF receptors | Q45165242 | ||
| Herpes simplex virus targeting to the EGF receptor by a gD-specific soluble bridging molecule | Q45496884 | ||
| Assembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titres of neutralizing antibodies | Q45789709 | ||
| Syndecan-1 Shedding Is Enhanced by LasA, a Secreted Virulence Factor ofPseudomonas aeruginosa | Q60148130 | ||
| 31 Quantification of matrix metalloproteinases in tissue samples | Q72059246 | ||
| A sensitive method to monitor ectodomain shedding of ligands of the epidermal growth factor receptor | Q79740236 | ||
| Surface-exposed amino acid residues of HPV16 L1 protein mediating interaction with cell surface heparan sulfate | Q80641249 | ||
| Carrageenan is a potent inhibitor of papillomavirus infection | Q21089628 | ||
| Two highly conserved cysteine residues in HPV16 L2 form an intramolecular disulfide bond and are critical for infectivity in human keratinocytes | Q21143868 | ||
| HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes | Q22252313 | ||
| The soluble serum protein Gas6 bridges virion envelope phosphatidylserine to the TAM receptor tyrosine kinase Axl to mediate viral entry | Q24299966 | ||
| Human papillomavirus infection requires cell surface heparan sulfate | Q24529079 | ||
| Atomic model of the papillomavirus capsid | Q24534499 | ||
| Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection | Q24537437 | ||
| A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes | Q24537580 | ||
| Current understanding of the mechanism of HPV infection | Q24616134 | ||
| Ectodomain shedding of epidermal growth factor receptor ligands is required for keratinocyte migration in cutaneous wound healing | Q24677883 | ||
| Identification of the alpha6 integrin as a candidate receptor for papillomaviruses | Q24678291 | ||
| Adenovirus Binding to Blood Factors Results in Liver Cell Infection and Hepatotoxicity | Q27469833 | ||
| Structural Basis of Oligosaccharide Receptor Recognition by Human Papillomavirus | Q27666101 | ||
| The emerging roles of serine protease cascades in the epidermis | Q28257226 | ||
| Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2 | Q28273441 | ||
| Function of the syndecans--a family of cell surface proteoglycans | Q28298962 | ||
| Animal cell mutants defective in glycosaminoglycan biosynthesis | Q28305815 | ||
| Establishment of human papillomavirus infection requires cell cycle progression | Q28474811 | ||
| Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial | Q28750269 | ||
| Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line | Q29547520 | ||
| Papillomaviruses and cancer: from basic studies to clinical application | Q29614745 | ||
| ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions | Q29615216 | ||
| Human papillomavirus is a necessary cause of invasive cervical cancer worldwide | Q29617514 | ||
| Functions of cell surface heparan sulfate proteoglycans | Q29618521 | ||
| Matrix metalloproteinases and the regulation of tissue remodelling | Q29618747 | ||
| Virus entry by endocytosis | Q29619724 | ||
| Vaccinia virus strains use distinct forms of macropinocytosis for host-cell entry | Q30435768 | ||
| Chlamydia trachomatis co-opts the FGF2 signaling pathway to enhance infection | Q31036531 | ||
| Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration | Q33188043 | ||
| Clathrin- and caveolin-independent entry of human papillomavirus type 16--involvement of tetraspanin-enriched microdomains (TEMs) | Q33374009 | ||
| Activation of EGFR on monocytes is required for human cytomegalovirus entry and mediates cellular motility | Q33563932 | ||
| Rapid dissociation of HIV-1 from cultured cells severely limits infectivity assays, causes the inactivation ascribed to entry inhibitors, and masks the inherently high level of infectivity of virions | Q33676520 | ||
| The role of furin in papillomavirus infection | Q33693739 | ||
| Maturation of papillomavirus capsids | Q33834872 | ||
| Human papillomavirus type 6b virus-like particles are able to activate the Ras-MAP kinase pathway and induce cell proliferation | Q33839349 | ||
| Human papillomavirus type 16 minor capsid protein l2 N-terminal region containing a common neutralization epitope binds to the cell surface and enters the cytoplasm | Q33850734 | ||
| The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes | Q33852592 | ||
| Alternative splicing of human papillomavirus type-16 E6/E6* early mRNA is coupled to EGF signaling via Erk1/2 activation | Q33859710 | ||
| Usage of heparan sulfate, integrins, and FAK in HPV16 infection | Q33905761 | ||
| The EGF receptor - an essential regulator of multiple epidermal functions | Q33923625 | ||
| Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan | Q34004909 | ||
| A new type of membrane raft-like microdomains and their possible involvement in TCR signaling. | Q34102524 | ||
| In Vivo Mechanisms of Vaccine-Induced Protection against HPV Infection | Q34125906 | ||
| Analysis of the infectious entry pathway of human papillomavirus type 33 pseudovirions. | Q34146670 | ||
| Papillomaviruses infect cells via a clathrin-dependent pathway | Q34187267 | ||
| Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses | Q34227402 | ||
| Cell surface heparan sulfate and its roles in assisting viral infections | Q34464575 | ||
| Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus | Q34535736 | ||
| Cell surface-binding motifs of L2 that facilitate papillomavirus infection | Q34743921 | ||
| Migration of growth factor-stimulated epithelial and endothelial cells depends on EGFR transactivation by ADAM17. | Q34781580 | ||
| Animal models of papillomavirus pathogenesis | Q35006173 | ||
| Keratinocyte-secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells | Q35024219 | ||
| Virus activated filopodia promote human papillomavirus type 31 uptake from the extracellular matrix | Q35659629 | ||
| Binding and internalization of human papillomavirus type 33 virus-like particles by eukaryotic cells | Q35839345 | ||
| Human papillomavirus type 31 uses a caveolin 1- and dynamin 2-mediated entry pathway for infection of human keratinocytes | Q36098845 | ||
| Inhibition of transfer to secondary receptors by heparan sulfate-binding drug or antibody induces noninfectious uptake of human papillomavirus | Q36099326 | ||
| MMPs and ADAMTSs: functional studies | Q36251025 | ||
| Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase | Q36316404 | ||
| Insights into the role of heparan sulphate in fibroblast growth factor signalling | Q36482135 | ||
| Mechanisms of human papillomavirus type 16 neutralization by l2 cross-neutralizing and l1 type-specific antibodies | Q36540127 | ||
| Interactions between heparan sulfate and proteins: the concept of specificity | Q36552851 | ||
| The role of syndecans in disease and wound healing | Q36578144 | ||
| Arrangement of L2 within the papillomavirus capsid | Q36673336 | ||
| Two AP1 sites binding JunB are essential for human papillomavirus type 18 transcription in keratinocytes | Q36698234 | ||
| Tumour microenvironment: laminin 332 in squamous-cell carcinoma | Q36800958 | ||
| Caveolin-1-dependent infectious entry of human papillomavirus type 31 in human keratinocytes proceeds to the endosomal pathway for pH-dependent uncoating | Q36898793 | ||
| Keratinocyte growth factor receptors | Q36954792 | ||
| Heparan sulfate-independent cell binding and infection with furin-precleaved papillomavirus capsids | Q36994627 | ||
| Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus | Q37099713 | ||
| The biological properties of cetuximab | Q37233886 | ||
| Growth factors and cytokines in wound healing | Q37364066 | ||
| Heparanase: busy at the cell surface | Q37371146 | ||
| Signal co-operation between integrins and other receptor systems | Q37396456 | ||
| Uterine cervical carcinoma: role of matrix metalloproteinases (review). | Q37415383 | ||
| The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding | Q37453403 | ||
| Autocrine extracellular signal-regulated kinase (ERK) activation in normal human keratinocytes: metalloproteinase-mediated release of amphiregulin triggers signaling from ErbB1 to ERK. | Q37497430 | ||
| The signaling mechanisms of syndecan heparan sulfate proteoglycans | Q37522781 | ||
| EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy | Q37609988 | ||
| Shedding; towards a new paradigm of syndecan function in cancer | Q37761400 | ||
| Proteoglycans in health and disease: the multiple roles of syndecan shedding | Q37788814 | ||
| Syndecans as cell surface receptors: Unique structure equates with functional diversity | Q37808303 | ||
| Papillomavirus particles assembled in 293TT cells are infectious in vivo | Q39304696 | ||
| Mechanism of HSV infection through soluble adapter-mediated virus bridging to the EGF receptor. | Q39580061 | ||
| Human papillomavirus type 31b infection of human keratinocytes and the onset of early transcription. | Q39685873 | ||
| An in vitro analysis of mechanical wounding-induced ligand-independent KGFR activation | Q39901167 | ||
| KGF and EGF signalling block hair follicle induction and promote interfollicular epidermal fate in developing mouse skin. | Q39976467 | ||
| Papillomavirus virus-like particles activate the PI3-kinase pathway via alpha-6 beta-4 integrin upon binding. | Q40266285 | ||
| Generation of HPV pseudovirions using transfection and their use in neutralization assays. | Q40340652 | ||
| Further evidence that papillomavirus capsids exist in two distinct conformations | Q40344553 | ||
| Tumor-targeted, systemic delivery of therapeutic viral vectors using hitchhiking on antigen-specific T cells | Q40371833 | ||
| Human papillomavirus type 31b infection of human keratinocytes does not require heparan sulfate | Q40423280 | ||
| Shuttle of lentiviral vectors via transplanted cells in vivo. | Q40512306 | ||
| Kinetics of in vitro adsorption and entry of papillomavirus virions | Q40589262 | ||
| Infectious human papillomavirus type 31b: purification and infection of an immortalized human keratinocyte cell line | Q40695908 | ||
| The human papillomavirus type 16 E5-protein modulates ligand-dependent activation of the EGF receptor family in the human epithelial cell line HaCaT. | Q41032558 | ||
| Expression of AP1 during cellular differentiation determines human papillomavirus E6/E7 expression in stratified epithelial cells | Q41131505 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P921 | main subject | virion | Q1757347 |
| P304 | page(s) | e1002519 | |
| P577 | publication date | 2012-02-09 | |
| P1433 | published in | PLOS Pathogens | Q283209 |
| P1476 | title | Essential roles for soluble virion-associated heparan sulfonated proteoglycans and growth factors in human papillomavirus infections | |
| P478 | volume | 8 |
| Q35913900 | A Dual Role for the Nonreceptor Tyrosine Kinase Pyk2 during the Intracellular Trafficking of Human Papillomavirus 16. |
| Q92168635 | A Human Papillomavirus-Independent Cervical Cancer Animal Model Reveals Unconventional Mechanisms of Cervical Carcinogenesis |
| Q39253672 | A transmembrane domain and GxxxG motifs within L2 are essential for papillomavirus infection |
| Q83232369 | ADAM17-dependent signaling is required for oncogenic human papillomavirus entry platform assembly |
| Q35076730 | Alpha-defensin HD5 inhibits furin cleavage of human papillomavirus 16 L2 to block infection. |
| Q39032783 | An L2 SUMO interacting motif is important for PML localization and infection of human papillomavirus type 16. |
| Q90634013 | Anatomy of a viral entry platform differentially functionalized by integrins α3 and α6 |
| Q36978897 | Annexin A2 and S100A10 regulate human papillomavirus type 16 entry and intracellular trafficking in human keratinocytes |
| Q47143249 | Antibody Competition Reveals Surface Location of HPV L2 Minor Capsid Protein Residues 17-36. |
| Q58617382 | Astaxanthin Prevents Human Papillomavirus L1 Protein Binding in Human Sperm Membranes |
| Q26784314 | Autophagy knocked down by high-risk HPV infection and uterine cervical carcinogenesis |
| Q36607050 | Cellular entry of human papillomavirus type 16 involves activation of the phosphatidylinositol 3-kinase/Akt/mTOR pathway and inhibition of autophagy. |
| Q36333638 | Cleavage of the HPV16 Minor Capsid Protein L2 during Virion Morphogenesis Ablates the Requirement for Cellular Furin during De Novo Infection |
| Q27026900 | Concepts of papillomavirus entry into host cells |
| Q39041312 | Cruising the cellular highways: How human papillomavirus travels from the surface to the nucleus |
| Q41676237 | Crystal Structures of Two Immune Complexes Identify Determinants for Viral Infectivity and Type-Specific Neutralization of Human Papillomavirus |
| Q28534531 | Differential dependence on host cell glycosaminoglycans for infection of epithelial cells by high-risk HPV types |
| Q64887908 | Diverse Papillomavirus Types Induce Endosomal Tubulation. |
| Q35871517 | Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancer |
| Q90437506 | Epidermal growth factor receptor and Abl2 kinase regulate distinct steps of Human papillomavirus type 16 endocytosis |
| Q52625020 | Extracellular conformational changes in the capsid of human papillomaviruses contribute to asynchronous uptake into host cells. |
| Q64056550 | Extracellular events impacting human papillomavirus infections: Epithelial wounding to cell signaling involved in virus entry |
| Q37073350 | Furin Cleavage of L2 during Papillomavirus Infection: Minimal Dependence on Cyclophilins |
| Q39320596 | HPV entry into cells |
| Q64938539 | HPV infection in semen: results from a new molecular approach. |
| Q47552780 | HPV-16 virions can remain infectious for 2 weeks on senescent cells but require cell cycle re-activation to allow virus entry |
| Q33714325 | HPV16 infection of HaCaTs is dependent on β4 integrin, and α6 integrin processing |
| Q36517471 | Heparin increases the infectivity of Human Papillomavirus type 16 independent of cell surface proteoglycans and induces L1 epitope exposure |
| Q36720700 | Herpes simplex virus downregulation of secretory leukocyte protease inhibitor enhances human papillomavirus type 16 infection. |
| Q58802346 | Heterotetrameric annexin A2/S100A10 (A2t) is essential for oncogenic human papillomavirus trafficking and capsid disassembly, and protects virions from lysosomal degradation |
| Q38042837 | Host-cell factors involved in papillomavirus entry |
| Q92789289 | How non-enveloped viruses hijack host machineries to cause infection |
| Q92128486 | Human DNA Virus Exploitation of the MAPK-ERK Cascade |
| Q57030254 | Human Papilloma Virus and Autophagy |
| Q47555803 | Human Papillomavirus 16 infection induces VAP-dependent endosomal tubulation |
| Q57473559 | Human Papillomavirus And Human Cytomegalovirus Infection And Association With Prognosis In Primary Glioblastoma Patients Of Pakistan |
| Q47555534 | Human papilloma virus: An etiological and prognostic factor for oral cancer? |
| Q36470809 | Human papillomavirus capsids preferentially bind and infect tumor cells |
| Q27003141 | Human papillomavirus induced transformation in cervical and head and neck cancers |
| Q38752656 | Human papillomavirus major capsid protein L1 remains associated with the incoming viral genome throughout the entry process |
| Q34774775 | Human papillomavirus species-specific interaction with the basement membrane-resident non-heparan sulfate receptor |
| Q37308756 | Identification of TRAPPC8 as a host factor required for human papillomavirus cell entry |
| Q33591582 | Impact of inhibitors and L2 antibodies upon the infectivity of diverse alpha and beta human papillomavirus types |
| Q36978121 | Incoming human papillomavirus type 16 genome resides in a vesicular compartment throughout mitosis |
| Q37712999 | Inhibition by cellular vacuolar ATPase impairs human papillomavirus uncoating and infection |
| Q33604135 | Inhibition of Langerhans cell maturation by human papillomavirus type 16: a novel role for the annexin A2 heterotetramer in immune suppression |
| Q57046578 | Inhibition of Tetraspanin Functions Impairs Human Papillomavirus and Cytomegalovirus Infections |
| Q36376623 | Interaction of human papillomavirus type 16 particles with heparan sulfate and syndecan-1 molecules in the keratinocyte extracellular matrix plays an active role in infection |
| Q35676027 | Interaction of human tumor viruses with host cell surface receptors and cell entry |
| Q35379573 | Intermediate heparan sulfate binding during HPV-16 infection in HaCaTs |
| Q35758680 | Kallikrein-8 Proteolytically Processes Human Papillomaviruses in the Extracellular Space To Facilitate Entry into Host Cells |
| Q37164879 | L2, the minor capsid protein of papillomavirus |
| Q27325402 | Large scale RNAi reveals the requirement of nuclear envelope breakdown for nuclear import of human papillomaviruses |
| Q37252724 | Multiple heparan sulfate binding site engagements are required for the infectious entry of human papillomavirus type 16. |
| Q36952911 | Nip the HPV encoded evil in the cancer bud: HPV reshapes TRAILs and signaling landscapes |
| Q35868083 | Opposing effects of bacitracin on human papillomavirus type 16 infection: enhancement of binding and entry and inhibition of endosomal penetration |
| Q26801497 | Papillomavirus Infectious Pathways: A Comparison of Systems |
| Q58764248 | Papillomaviruses and Endocytic Trafficking |
| Q59357757 | Preparation and characterization of functionalized heparin-loaded poly-Ɛ-caprolactone fibrous mats to prevent infection with human papillomaviruses |
| Q37599123 | Preparation and properties of a papillomavirus infectious intermediate and its utility for neutralization studies |
| Q38045782 | Principles of polyoma- and papillomavirus uncoating |
| Q38087843 | Regulation of human papillomavirus gene expression by splicing and polyadenylation |
| Q46251800 | Rodent Papillomaviruses. |
| Q39250951 | SNX17 facilitates infection with diverse papillomavirus types |
| Q47110116 | Subcellular Trafficking of the Papillomavirus Genome during Initial Infection: The Remarkable Abilities of Minor Capsid Protein L2. |
| Q50043357 | Superinfection Exclusion between Two High-Risk Human Papillomavirus (HPV) Types During a Co-Infection |
| Q53507564 | Syndecan-1 Acts in Synergy with Tight Junction Through Stat3 Signaling to Maintain Intestinal Mucosal Barrier and Prevent Bacterial Translocation. |
| Q55084010 | Tetraspanin Assemblies in Virus Infection. |
| Q24307905 | Tetraspanin CD151 mediates papillomavirus type 16 endocytosis |
| Q94571426 | Tetraspanin CD9 affects HPV16 infection by modulating ADAM17 activity and the ERK signalling pathway |
| Q38837603 | Tetraspanins in infections by human cytomegalo- and papillomaviruses |
| Q40557268 | The CD63-Syntenin-1 Complex Controls Post-Endocytic Trafficking of Oncogenic Human Papillomaviruses |
| Q35624920 | The HPV16 and MusPV1 papillomaviruses initially interact with distinct host components on the basement membrane |
| Q93048605 | The Known and Potential Intersections of Rab-GTPases in Human Papillomavirus Infections |
| Q47551866 | The Role of E6 Spliced Isoforms (E6*) in Human Papillomavirus-Induced Carcinogenesis |
| Q21134079 | The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infection |
| Q90705077 | The Underlying Mechanism of 3-Hydroxyphthalic Anhydride-Modified Bovine Beta-Lactoglobulin to Block Human Papillomavirus Entry Into the Host Cell |
| Q38064068 | The biology and life-cycle of human papillomaviruses. |
| Q64096696 | The endocytic trafficking pathway of oncogenic papillomaviruses |
| Q36827213 | The evolving field of human papillomavirus receptor research: a review of binding and entry. |
| Q37198519 | The papillomavirus major capsid protein L1. |
| Q26748610 | The signaling involving in autophagy machinery in keratinocytes and therapeutic approaches for skin diseases |
| Q37611844 | The tetraspanin CD151 in papillomavirus infection |
| Q64286426 | The viral protein corona directs viral pathogenesis and amyloid aggregation |
| Q36086288 | Topography of the Human Papillomavirus Minor Capsid Protein L2 during Vesicular Trafficking of Infectious Entry. |
| Q36303591 | Use of an in vivo animal model for assessing the role of integrin α(6)β(4) and syndecan-1 in early steps in papillomavirus infection |
| Q38701705 | Vimentin Modulates Infectious Internalization of Human Papillomavirus 16 Pseudovirions. |
Search more.